FR2183669B1 - - Google Patents

Info

Publication number
FR2183669B1
FR2183669B1 FR7305136A FR7305136A FR2183669B1 FR 2183669 B1 FR2183669 B1 FR 2183669B1 FR 7305136 A FR7305136 A FR 7305136A FR 7305136 A FR7305136 A FR 7305136A FR 2183669 B1 FR2183669 B1 FR 2183669B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7305136A
Other languages
French (fr)
Other versions
FR2183669A1 (ru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Original Assignee
CH Boehringer Sohn AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CH Boehringer Sohn AG and Co KG filed Critical CH Boehringer Sohn AG and Co KG
Publication of FR2183669A1 publication Critical patent/FR2183669A1/fr
Application granted granted Critical
Publication of FR2183669B1 publication Critical patent/FR2183669B1/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7305136A 1972-02-14 1973-02-14 Expired FR2183669B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2206867A DE2206867A1 (de) 1972-02-14 1972-02-14 Mittel zur magensaftsekretionshemmung und ulcusbehandlung

Publications (2)

Publication Number Publication Date
FR2183669A1 FR2183669A1 (ru) 1973-12-21
FR2183669B1 true FR2183669B1 (ru) 1976-07-02

Family

ID=5835916

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7305136A Expired FR2183669B1 (ru) 1972-02-14 1973-02-14

Country Status (8)

Country Link
AU (1) AU474663B2 (ru)
BE (1) BE795383A (ru)
DE (1) DE2206867A1 (ru)
FR (1) FR2183669B1 (ru)
GB (1) GB1415055A (ru)
IL (1) IL41524A (ru)
NL (1) NL7301995A (ru)
ZA (1) ZA731001B (ru)

Also Published As

Publication number Publication date
IL41524A0 (en) 1973-04-30
GB1415055A (en) 1975-11-26
AU474663B2 (en) 1976-07-29
AU5211573A (en) 1974-08-15
NL7301995A (ru) 1973-08-16
FR2183669A1 (ru) 1973-12-21
ZA731001B (en) 1974-11-27
DE2206867A1 (de) 1973-08-23
BE795383A (fr) 1973-08-13
IL41524A (en) 1976-03-31

Similar Documents

Publication Publication Date Title
JPS53370B2 (ru)
CS152934B1 (ru)
CS152948B1 (ru)
CS153311B1 (ru)
CS154480B1 (ru)
CS156584B1 (ru)
CS156323B1 (ru)
CH571386A5 (ru)
CH575408A5 (ru)
CH559550A5 (ru)
CH559598A5 (ru)
CH560410A (ru)
CH560870A5 (ru)
CH561670A5 (ru)
CH562334A5 (ru)
CH563553A5 (ru)
CH563676A5 (ru)
CH563766A5 (ru)
CH564948A5 (ru)
CH565321A5 (ru)
CH566566A5 (ru)
CH567900A5 (ru)
CH570340A5 (ru)
CH570822A5 (ru)
CH441173A4 (ru)

Legal Events

Date Code Title Description
ST Notification of lapse